113 related articles for article (PubMed ID: 21664283)
1. Human aggrecanase generated synovial fluid fragment levels are elevated directly after knee injuries due to proteolysis both in the inter globular and chondroitin sulfate domains.
Struglics A; Hansson M; Lohmander LS
Osteoarthritis Cartilage; 2011 Aug; 19(8):1047-57. PubMed ID: 21664283
[TBL] [Abstract][Full Text] [Related]
2. Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases.
Struglics A; Larsson S; Hansson M; Lohmander LS
Osteoarthritis Cartilage; 2009 Apr; 17(4):497-506. PubMed ID: 19095471
[TBL] [Abstract][Full Text] [Related]
3. Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus.
Struglics A; Lohmander LS; Last K; Akikusa J; Allen R; Fosang AJ
Arthritis Rheum; 2012 Dec; 64(12):4151-61; author reply 4162-3. PubMed ID: 22886575
[TBL] [Abstract][Full Text] [Related]
4. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.
Larsson S; Lohmander LS; Struglics A
Arthritis Res Ther; 2009; 11(3):R92. PubMed ID: 19545413
[TBL] [Abstract][Full Text] [Related]
6. A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs.
Swearingen CA; Chambers MG; Lin C; Marimuthu J; Rito CJ; Carter QL; Dotzlaf J; Liu C; Chandrasekhar S; Duffin KL; Mitchell PG; Durham TB; Wiley MR; Thirunavukkarasu K
Osteoarthritis Cartilage; 2010 Sep; 18(9):1159-66. PubMed ID: 20633676
[TBL] [Abstract][Full Text] [Related]
7. Calpain is involved in C-terminal truncation of human aggrecan.
Struglics A; Hansson M
Biochem J; 2010 Sep; 430(3):531-8. PubMed ID: 20618160
[TBL] [Abstract][Full Text] [Related]
8. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
[TBL] [Abstract][Full Text] [Related]
9. An ARGS-aggrecan assay for analysis in blood and synovial fluid.
Larsson S; Lohmander LS; Struglics A
Osteoarthritis Cartilage; 2014 Feb; 22(2):242-9. PubMed ID: 24361794
[TBL] [Abstract][Full Text] [Related]
10. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
Sandy JD; Verscharen C
Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation.
Chockalingam PS; Glasson SS; Lohmander LS
Osteoarthritis Cartilage; 2013 Feb; 21(2):339-45. PubMed ID: 23142724
[TBL] [Abstract][Full Text] [Related]
12. Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor.
Chockalingam PS; Sun W; Rivera-Bermudez MA; Zeng W; Dufield DR; Larsson S; Lohmander LS; Flannery CR; Glasson SS; Georgiadis KE; Morris EA
Osteoarthritis Cartilage; 2011 Mar; 19(3):315-23. PubMed ID: 21163358
[TBL] [Abstract][Full Text] [Related]
13. Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)--a cross-sectional analysis.
Swärd P; Frobell R; Englund M; Roos H; Struglics A
Osteoarthritis Cartilage; 2012 Nov; 20(11):1302-8. PubMed ID: 22874525
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine.
Swearingen CA; Carpenter JW; Siegel R; Brittain IJ; Dotzlaf J; Durham TB; Toth JL; Laska DA; Marimuthu J; Liu C; Brown DP; Carter QL; Wiley MR; Duffin KL; Mitchell PG; Thirunavukkarasu K
Osteoarthritis Cartilage; 2010 Sep; 18(9):1150-8. PubMed ID: 20633682
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.
Pratta MA; Su JL; Leesnitzer MA; Struglics A; Larsson S; Lohmander LS; Kumar S
Osteoarthritis Cartilage; 2006 Jul; 14(7):702-13. PubMed ID: 16549371
[TBL] [Abstract][Full Text] [Related]
16. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
17. Cartilage metabolism in the injured and uninjured knee of the same patient.
Dahlberg L; Roos H; Saxne T; Heinegård D; Lark MW; Hoerrner LA; Lohmander LS
Ann Rheum Dis; 1994 Dec; 53(12):823-7. PubMed ID: 7864691
[TBL] [Abstract][Full Text] [Related]
18. Relationship between synovial fluid ARGS-aggrecan fragments, cytokines, MMPs, and TIMPs following acute ACL injury: A cross-sectional study.
Tourville TW; Poynter ME; DeSarno MJ; Struglics A; Beynnon BD
J Orthop Res; 2015 Dec; 33(12):1796-803. PubMed ID: 26123869
[TBL] [Abstract][Full Text] [Related]
19. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: Use as a biomarker for aggrecanase activity and cartilage degradation.
Dufield DR; Nemirovskiy OV; Jennings MG; Tortorella MD; Malfait AM; Mathews WR
Anal Biochem; 2010 Nov; 406(2):113-23. PubMed ID: 20603097
[TBL] [Abstract][Full Text] [Related]
20. Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C-Terminal Crosslinking Telopeptide of Type II Collagen and N-Terminal Crosslinking Telopeptide of Type I Collagen in Urine Over Five Years After Anterior Cruciate Ligament Rupture: An Exploratory Analysis in the Knee Anterior Cruciate Ligament, Nonsurgical Versus Surgical Treatment Trial.
Struglics A; Larsson S; Kumahashi N; Frobell R; Lohmander LS
Arthritis Rheumatol; 2015 Jul; 67(7):1816-25. PubMed ID: 25914389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
